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Abstract
Background: L-tryptophan is an aromatic amino acid widely used in the food, chemical and pharmaceutical
industries. In Escherichia coli, L-tryptophan is synthesized from phosphoenolpyruvate and erythrose 4-phosphate by
enzymes in the shikimate pathway and L-tryptophan branch pathway, while L-serine and
phosphoribosylpyrophosphate are also involved in L-tryptophan synthesis. In order to construct a microbial strain
for efficient L-tryptophan production from glucose, we developed a one step tryptophan attenuator inactivation
and promoter swapping strategy for metabolic flux optimization after a base strain was obtained by overexpressing
the tktA, mutated trpE and aroG genes and inactivating a series of competitive steps.
Results: The engineered E. coli GPT1002 with tryptophan attenuator inactivation and tryptophan operon promoter
substitution exhibited 1.67 ~ 9.29 times higher transcription of tryptophan operon genes than the control GPT1001.
In addition, this strain accumulated 1.70 g l
-1 L-tryptophan after 36 h batch cultivation in 300-mL shake flask.
Bioreactor fermentation experiments showed that GPT1002 could produce 10.15 g l
-1 L-tryptophan in 48 h.
Conclusions: The one step inactivating and promoter swapping is an efficient method for metabolic engineering.
This method can also be applied in other bacteria.
Background
L-tryptophan is an essential aromatic amino acid for
humans and animals which can be used as food additive,
infusion liquids, pellagra treatment, sleep induction and
nutritional therapy [1,2]. Since the chemical synthesis of
L-tryptophan has many disadvantages such as nonre-
newable toxic raw materials and racemic mixtures of
products, microbial fermentation of L-tryptophan has
become attractive alternative. E. coli, a widely used pro-
duction host that possesses clear genetic background,
convenient metabolic engineering tools and fast growth
in cheap media, has attracted many attentions for the
production of L-tryptophan and other aromatic com-
pounds [3-7].
The biosynthesis of the L-tryptophan in E. coli begins
with the condensation of phosphoenolpyruvate (PEP)
and erythrose 4-phosphate (E4P) to form 3-deoxy-D-
arabino-heptulosonate-7-phosphate (DAHP), and then
proceeds to chorismate, a key intermediate product
leading to the formation of L-tryptophan, L-tyrosine,
and L-phenylalanine (Figure 1). In the L-tryptophan
branch pathway, L-serine and phosphoribosylpyropho-
sphate (PRPP) are needed as well. Since the biosynthesis
of L-tryptophan from glucose involves a long metabolic
pathway, there are several regulatory circuits which
influence the accumulation of L-tryptophan such as
transcriptional repression, attenuation, feedback inhibi-
tion and so on [1,8]. Among these regulatory circuits,
tryptophan attenuator is critical due to its sensitivity to
the in vivo L-tryptophan level [9].T h e r e f o r e ,r e m o v i n g
or inactivating the tryptophan attenuator was supposed
to be an effective method for elevating the L-tryptophan
accumulation. Herry et al. identified a mutation in the
tryptophan attenuator sequence from a hyperproducing
strain of Corynebacterium glutamicum a n dp r o v e di t s
contribution to the deregulation of the tryptophan
operon [10]. However, little attention had been focused
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duction in E. coli.
Otherwise, the transcription and expression of trypto-
phan operon is pivotal to obtain high L-tryptophan
accumulation as well [6]. Promoter swapping allowed
researchers to replace a wild type promoter with the
one that has been designed for a increased or controlled
transcription strength while retaining the natural genetic
context of a gene or an operon in the genome [11].
Consequently, by promoter swapping and engineering,
the targeted metabolites can be elevated. For example,
to maximize the threonine production, Lee at al. created
an L-threonine producing strain by replaced three differ-
ent chromosomal promoters. After replaced the native
promoter of the ppc gene with trc promoter in the chro-
mosome, the engineered strain showed a higher PPC
flux than the wild type, and therefore resulting 27.7%
increased threonine production [12]. In another study,
Alper et al. found a correlation between promoter
strength and lycopene production. By introducing a pro-
moter library that was created by error-prone PCR into
E. coli to replace native promoter of phosphoenolpyru-
vate carboxylase or deoxy-xylulose-phosphate synthase,
they identified a suitable promoter for lycopene produc-
tion [13].
In this study, we first constructed a basic L-trypto-
phan-synthetic strain by inactivation of the trpR, tnaA
and ptsG, expressing in plasmids the feedback resistant
aroG, trpE (aroG
FR and trpE
FR respectively), and tktA
genes in wild E. coli K-12 W3110. Then, we inactivated
the tryptophan attenuator and replacing the original trp
promoter of tryptophan operon with a novel promoter
cluster consisted of five core-tac-promoters aligned in
tandem (5CPtacs promoter cluster) in one step. The
resulting strain GPT1002 showed higher transcription of
tryptophan operon genes and more L-tryptophan accu-
mulation than the parent strain.
Results and discussion
Construction of the basic L-tryptophan-synthetic E. Coli
GPT1001
The overall strategies for constructing L-tryptophan pro-
duction strain are shown in Figure 1. To generate an E.
coli that overproduces and excretes L-tryptophan, the fol-
lowing manipulation was done: First, trpR gene, which
encodes a tryptophan transcriptional repressor, was
knocked out to eliminate transcription regulation of the
g e n e si nL - t r y p t o p h a np a t h w a y[ 6 , 1 4 ] .K n o c k o u to ft h i s
gene slightly improved the tryptophan accumulation
(Table 1). Second, trpE and aroG, encoding component I
of anthranilate synthase and DAHP synthase, respec-
tively, were cloned into the low-copy-number vector
pCL1920 and were expressed in the E. coli (ΔtrpR). Since
the expression of wild type trpE and aroG are feedback
inhibited by L-tryptophan and L-phenylalanine, respec-
tively, site-directed mutations of trpE (Met293Thr) and
aroG (Pro150Leu) were performed in our study to
remove the feedback inhibition [15,16]. The resulting
recombinant E. coli (ΔtrpR) harboring the overexpressed
and mutated trpE and aroG can produce 0.74 g l
-1 L-
tryptophan in batch cultivation, which is 6000 fold higher
than the wild type E. coli (Table 1).
Figure 1 The strategies for constructing the L-tryptophan producing strain GPT1002. The shaded boxes represent genetic modification,
and the gray bars indicate the genes that were deleted. Dotted lines indicate feedback inhibition. The black X indicates that the inhibition is
removed. The thick black arrows indicate the increased flux or activity by directly overexpressing the corresponding genes in plasmids. Glc
glucose, G6P glucose-6-phosphate, E4P erythrose-4-phosphate, PEP phosphoenolpyruvate, DAHP 3-deoxy-D-arabino-heptulosonate, CHA
chorismate, ANTA anthranilate, L-Phe L-phenylalanine, L-Tyr L-tyrosine, L-Trp L-tryptophan, tktA transketolase, aroG 3-deoxy-D-arabino-
heptulosonate-7-phosphate synthase (phenylalanine repressible), trpE component I of anthranilate synthase, trpR trp operon repressor, tnaA
tryptophanase, ptsG glucose-specific PTS enzyme IIBC components, manXYZ mannose-specific PTS enzyme IIABCD components, galP D-galactose
transporter, PP pathway pentose phosphate pathway.
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increased the expression of the key enzymes in the tryp-
tophan biosynthesis pathway, while provision of more
precursors would enable the enhanced metabolic flux.
tktA gene, encoding a transketolase in pentose phos-
phate pathway, and overexpression of this gene in E.
coli was proved to supply more E4P, a precursor of L-
tryptophan [17]. Otherwise, carbon flux distribution
analysis at the node in wild E. coli indicated that phos-
phoenolpyruvate:carbohydrate phosphotransferase sys-
tem (PTS) is the largest consumer of PEP, while the
relative carbon flux directed to aromatic amino acid bio-
synthesis is only around 1.5% of the PTS consumed [18].
Therefore we knocked out ptsG, which encodes the IIBC
component of glucose-specific PTS system, to provide
more PEP. In our base strain, we performed modifica-
tion of the host to increase the levels of precursors PEP
and E4P, while PRPP and Lserine are also building
blocks for L-tryptophan. Therefore, increasing the avail-
ability of L-serine by amplification of the deregulation
serA gene [19] and PRPP by overexpresssion of prs and
ywlF genes involved in the biosynthetic pathway of
PRPP from ribulose-5-phosphate [20] should be useful
for high L-tryptophan accumulation. Finally, we knocked
out the gene tnaA, which encodes a tryptophanase that
catalyzes the reaction of L-tryptophan back into indole
[3]. The resulting L-tryptophan-synthetic strain was
named GPT100. Then we transformed plasmid pTAT
into E. coli GPT100 and constructed strain GPT1001.
This strain was able to produce 1.3 g l
-1 L-tryptophan in
batch cultivation and was therefore used as base strain
for further experiment.
One-step L-tryptophan attenuator inactivation and
promoter swapping
The expression of tryptophan biosynthesis operon was
negatively regulated by the attenuator downstream of
the promoter operator site until tryptophan starvation is
severe. However, simply removal of the attenuator
probably cannot reach a sufficient expression of the
tryptophan operon genes [21]. Therefore it is essential
to improve the expression of genes in tryptophan
operon at the same time of inactivating the attenuator.
Therefore we developed a one step attenuator inacti-
vation and promoter swapping method (Figure 2). First,
we constructed a recombinant plasmid pKMT, which
contains the kan gene from pKD4 and 5CPtacs promo-
ter cluster from p5TG. Previous work of our laboratory
verified the transcription strength can be enhanced by
increasing the tandem repeats of the core-tac-promoter
and reached almost the maximum if the tandem repeti-
tive number was five [22]. At the both side of kan gene,
FRT sites were added. Then using this plasmid as tem-
plate, the integration cassette was constructed employ-
ing PCR by adding at upstream of 5CPtacs promoter
cluster and downstream of kan gene the 39 bp homolo-
gous sequences for Red recombination. Finally, by elec-
troporating the fragments into cells of base strain E. coli
GPT100, the engineered E. coli GPT101 that contains
the inactivated attenuator and swapped promoter was
obtained. Among twenty-four recombinants that were
detected, only one positive clone was found. The posi-
tive clone was transformed with plasmid pTAT, result-
ing strain E. coli GPT1002.
Characterization of tryptophan operon transcription in E.
Coli GPT1002
To investigate the effect of the tryptophan attenuator
inactivation and promoter replacement, the transcription
of five tryptophan operon genes in the strains GPT1002
and GPT1001 was compared employing RT-PCR (Figure
3A). Compared to that of the control strain GPT1001,
the transcription of five tryptophan operon genes in
GPT1002 was up-regulated from 1.67 ± 0.04 to 9.21 ±
0.13 times. Among that, the first gene trpE,d i r e c t
downstream of the 5CPtacs promoter cluster was signifi-
cantly up-regulated by 9.21 ± 0.13 times. Nevertheless,
other four genes in the tryptophan operon were only
about two times up-regulated. A recent publication also
reported the differential expression of the genes in the
same operon [23]. They found that the gene expression
in the operon has linear relationship with the transcrip-
tion distance. They even created a general model of
operon translation to elucidate this phenomenon. How-
ever, in our study, we found that trpD, trpC, trpB,a n d
trpA genes with different transcription distance in the
operon had similar transcription level. The differences
between our and their experiment is that we use the
natural operon. Natural operon has some specific regu-
latory mechanisms, while synthetic operons used in
their experiments lacked those mRNA-specific, regula-
tory mechanisms commonly found in native operons
[23]. In native tryptophan operon, besides trp promoter
Table 1 Development of L-tryptophan producing E. coli
strains
Strain L-tryptophan (mg l
-1)
W3110 0.12 ± 0.01
W3110 (ΔtrpR::FRT) 0.14 ± 0.02
W3110 (ΔtrpR::FRT)/pCL1920-trpE
FR 64.46 ± 2.17
W3110 (ΔtrpR::FRT)/pCL1920-trpE
FR-aroG
FR 736.83 ± 3.98
W3110 (ΔtrpR::FRT)/pTAT 1018.98 ± 1.89
W3110 (ΔtrpR::FRT, ΔtnaA::FRT)/pTAT 1188.20 ± 2.56
W3110 (ΔtrpR::FRT, ΔtnaA::FRT, ΔptsG::FRT)/pTAT
a 1208.82 ± 1.33
L-tryptophan titer in mg l
-1 reported was the final production obtained when
glucose had been completely consumed in 50 mL fermentative medium
containing 20 g l
-1 glucose, shaken at 250 rpm and 37°C.
a E.coli GPT1001
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an internal low efficiency promoter trp p2 located
within trpD gene providing a bypass function advanta-
geous to the cell under conditions of severe nutritional
deprivation [24-27]. However, the regulation mechanism
of promoter trp p2 is still unknown, which may influ-
ence the transcription of tryptophan operon and lead
our novel results.
Figure 2 Outline of plasmid pKMT construction and promoter swapping.
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the strain GPT1002 was also significantly upregulated
by 9.29 ± 0.32 fold. In order to determine whether the
different expression levels of trpE and aroG on the plas-
mid pTAT lead to this phenomenon, we analyzed the
expression of trpE, aroG and trpD in the strain GPT101
and GPT100, the parent strains of GPT1002 and
GPT1001 without the recombinant plasmid pTAT,
respectively (Figure 3B). The relative transcription of
three genes in both GPT101 and GPT100 were similar
to the strain harboring pTAT, and therefore excluded
the impact of plasmid pTAT. Since AroG protein is cri-
tical of controlling the carbon flow into aromatic amino
acid biosynthesis pathway [28,29], more experiments
such as metabolic flux analysis should be helpful to find
out the reason of high aroG transcription.
Production of L-tryptophan by E. Coli GPT1002
To explore the effect of attenuator inactivation and pro-
moter swapping on L-tryptophan production, we per-
formed batch cultivation of the engineered strain
GPT1002 and the control GPT1001 in the medium sup-
plemented with 20 g l
-1 glucose (Figure 4). Strain
GPT1001 and GPT1002 showed a similar glucose con-
sumption rate, but GPT1002 grew a little faster than the
control, indicated by the optical density 600 nm
(OD600) at 36 h, 15.2 vs 13.2. This implied that the
genetic modification of the L-tryptophan operon may
improved the glucose utilization efficiency. After 36 h
cultivation, GPT1002 accumulated 1.70 g l
-1 L-trypto-
phan, 30.8% higher than that of the control strain
GPT1001.
To evaluate the L-tryptophan production potential of
E. coli strain GPT1002 under controlled conditions, we
performed bioreactor fermentations under indicated cul-
tivation condition (Figure 5). Strain GPT1002 showed a
long lag growth phase of about 20 h. During this period,
the L-tryptophan also accumulated at low level. This
long lag growth phase may be due to the metabolic bur-
den generated by 5CPtacs promoter cluster swapping
and plasmid pTAT. After 20 h, the cell growth entered
the exponential phase. Simultaneously, the production
of L-tryptophan began to increase rapidly. The maxi-
mum OD600 was 53, while, the maximum L-tryptophan
accumulation reached 10.15 g l
-1 at 48 h. Since
GPT1002 is a genetically well-defined strain, of which
the development is directly related to L-tryptophan bio-
synthesis, it can be easily improved by means of omics
method or adapted evolution, as a lot of large-scale ana-
lytical techniques such as transcriptome and proteome
analysis in this regard can be help [12,30].
Through promoter swapping, a wild type promoter
could be replaced with the one that has been designed
for increased or controlled transcription strength
[31,32]. However, a normal strong promoter is
Figure 3 RT-PCR analysis of constructed E. coli. (A) Relative gene expression of E. coli GPT1002 to the control GPT1001. (B) Relative gene
expression of E. coli GPT101 to the control GPT100. gapA transcripts was selected as standard and each measurements were repeated three
times. The error bars indicate standard deviations.
Figure 4 Batch cultivation of E. coli GPT1001 and GPT1002 in
300-mL shake flasks. For E. coli GPT1001, (filled square) growth
curves; (filled circle) glucose consumption; (filled triangle) L-
tryptophan yield. For E. coli GPT1002, (open square) growth curves;
(open circle) glucose consumption; (open triangle) L-tryptophan
yield. The error bars represent standard deviations from three
replicate fermentations.
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sion. Recently, we developed a promoter cluster, by
which the core tac promoter region was arranged repeti-
tively in tandem. This method can improve the expres-
sion of desired genes without increasing the copy
number of the gene. When the repetition number was
5, the transcription strength increased almost 4 fold
[22]. In this study, the 5CPtacs promoter cluster was
swapped into the upstream region of tryptophan operon,
which resulted in an ideal result. Besides E.coli, this pro-
moter swapping method can also be applied in many
other bacteria and other regions of the chromosome.
Nevertheless, the choice of swapping region in the chro-
mosome is very important. When the swapping region
contains indispensable gene or essential regulation ele-
ments, the swapping should be careful.
Conclusions
We developed a method for one step inactivating the
tryptophan attenuator and promoter swapping. The
engineered E. coli GPT1002 showed strong transcription
capability and L-tryptophan accumulation. The L-trypto-
phan production of GPT1002 can be further improved
through strain improvement and fermentation process
optimization. The one step gene inactivating and pro-
moter swapping is an efficient method for metabolic
engineering and can also be applied in other bacteria.
Methods
Bacterial strains and plasmids construction
All strains, plasmids and oligonucleotides used in this
s t u d yw e r el i s t e di nT a b l e2a n dT a b l e3 .E. coli K-12
W3110 was selected for engineering of the basic L-tryp-
tophan-synthetic strain. E.coli strain DH5a was used as
the host of recombinant DNA manipulation. Plasmid
pCL1920 [33] was used to construct pTAT. Site-directed
mutation of trpE (Met293Thr) and aroG (Pro150Leu)
encoding component I of anthranilate synthase and 3-
deoxy-D-arabino-heptulosonate-7-phosphate synthase
respectively were performed by Easy Mutagenesis Sys-
tem from TransGene Biotech (Beijing, China) according
to the manufacturer. Successful mutations were verified
by sequencing in the BioSune Company (Shanghai,
China). The trpE
FR, aroG
FR,a n dtktA fragments were
amplified by PCR using trpE
FR-F and trpE
FR-R, aroG
FR-
Fa n da r o G
FR-R, and tktA-F and tktA-R as the primers
respectively. Then the three genes were digested with
HindIII/PstI, PstI/BamHI, and BamHI/SacI( F e r m e n t a s )
separately and ligated into cloning vector pCL1920 by
T4 ligase (New England Biolabs, USA) in turn, obtaining
the recombinant plasmid pTAT.
Plasmid pBluescript SK
- was served for constructing
recombinant vector pKMT. The kan gene and the
5CPtacs promoter cluster were obtained with the kan-F
and kan-R, and Mtac-F and Mtac-R as the primers and
the plasmids pKD4 and p5TG as the templates sepa-
rately using the TransTaq DNA Polymerase High Fide-
lity from TransGene Biotech (Beijing, China). Next, the
PCR products were digested with BamHI/EcoRI and
EcoRI/SacI respectively, and then ligated into the vector
pBluscript SK
- and constructed the plasmid pKMT.
Gene inactivation
Three genes trpR, tnaA,a n dptsG, which encoded trp
operon repressor, tryptophanase, and glucose-specific
PTS enzyme IIBC components respectively, were inacti-
v a t e di nt u r nu s i n gt h eo n e - s tep inactivation method
[34]. Primers trpR-F and trp-R, tnaA-F and tnaA-R, and
ptsG-F and ptsG-R, template plasmids pKD3 for ptsG
and pKD4 for trpR and tnaA were used to obtain the
linearized DNA flanked by FLP recognition target sites
and homologous sequences for genes deletion. The PCR
was performed in an automated thermocycler (Bio-Rad,
Hercules, CA, USA), and then PCR products were gel-
purified and digested with DpnI. Electroporation was
done according to the manufacturer’s instructions by
using 25 ml of cells and 10-100 ng of PCR product to
transform resistance gene cassette into the cells expres-
sing the Red recombinase before. Shocked cells were
added to 1 ml SOC cultures, incubated 1 h at 37°C, and
one-half was spread onto agar to select chlorampenicol
resistant or kanamycin resistant transformants. Positive
clones on the plates were verified by PCR using the pri-
mers trpRtest-F and trpRtest-R, tnaAtest-F and tnaAt-
est-R, and ptsGtest-F and ptsGtest-R separately. The
chlorampenicol or kanamycin cassette was removed
with the helper plasmid pCP20. The final strain E. coli
K-12 W3110 with three mutations (ΔtrpR ΔtnaA
ΔptsG) was named GPT100.
Figure 5 Fed-batch fermentation of GPT1002 in 5-L
fermentator. (Filled square) growth curves; (filled circle) glucose
consumption; (filled triangle) L-tryptophan yield. The error bars
represent standard deviations from three measurements.
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promoter swapping
The DNA fragment for next promoter replacement was
amplified using plasmid pKMT as the template with the
primers Trp-F and Trp-R and the fragment containing
kan gene and 5CPtacs promoter cluster was transformed
into GPT100 by electroporation, incubated for 1 hours
at 37°C, and spread onto agar to select kanamycin resis-
tant transformants. The strategy of plasmid pKMT con-
struction and promoter swapping were listed in Figure
2 .T h ep o s i t i v ec l o n e sw e r ev e r i f i e db yP C Ru s i n gt h e
primers trptest-F and trptest-R, and named GPT101.
Then we transformed the plasmid pTAT into GPT101
and the GPT100 respectively, and resulting to the
recombinant strain GPT1002 and control strain
GPT1001 for next experiments.
Quantitative real-time reverse transcription (RT)-PCR
analysis
Samples for mRNA preparation were cultivated 6 h after
the addition of 0.1 mM IPTG if necessary. Total cellular
RNA was extracted by the RNA simple Total RNA Kit
(TIANGEN, Beijing, China) as described by the manu-
facturer. The quantity and purity of RNA were deter-
mined by spectrophotometrically at A260 and A280.T h e
reverse transcription was performed using primers Ran-
dom 6 mers and Oligo dT by the PrimeScript RT
reagent Kit (TaKaRa, China) according to the manufac-
turer. RT- PCR was performed with SYBR Premix Ex
TaqII (TaKaRa, China) followed the protocol of the
Real-Time PCR Detection Systems (Bio-Rad, Hercules,
CA, USA). The RT-PCR measurement was repeated
three times for each sample. The trpE, trpD, trpC, trpB,
trpA, aroG genes transcripts primers were listed in
Table 3 and gapA encoding D-glyceraldehyde-3-phos-
phate dehydrogenase transcript selected as internal stan-
dard was amplified with gapART-F and gapART-R.
Growth conditions
Strains for cloning and inoculums were grown in
Luria-Bertani media (1% tryptone, 0.5% yeast extract
and 1% NaCl) at 37°C for 8-12 h supplemented with
the appropriate antibiotic (ampicillin (100 mg l
-1),
chloramphenicol (17 mg l
-1), kanamycin (25 mg l
-1),
spectinomycin (50 mg l
-1)) when necessary. For fer-
mentation, the seed medium contained (per liter) glu-
cose (20 g), MgSO4·7H2O( 5g ) ,K H 2PO4 (1.5 g),
(NH4)2SO4 (10 g), yeast extract (15 g), FeSO4·7H2O
(15 mg), sodium citrate dehydrate (0.5 g), Vitamin B1
(100 mg). The fermentative medium contained (per
liter) glucose (20 g), MgSO4·7H2O( 5g ) ,K H 2PO4 (2
g), (NH4)2SO4 (4 g), yeast extract (1 g), FeSO4·7H2O
(100 mg), sodium citrate dehydrate (2 g). A single
clone was pre-cultured in 5 ml Luria-Bertani medium
at 37°C and on a rotary shaker at 200 rpm overnight.
1 ml overnight cells were inoculated into 50 ml seed
medium and cultured for 8-12 hours, and then 10%
(v/v) seed cultures for batch cultivation were incu-
bated into 50 mL fermentation medium at 37°C with
the initial glucose concentration 20 g l
-1.I s o p r o p y lb-
D-1-thiogalactopyranoside (IPTG) was added at the
final concentration of 0.2 mM. For fed-batch fermen-
tation, a stirred 5-l glass vessel with the BioFlo310
modular fermentor system (New Brunswick Scientific,
Edison, NJ, USA) was used. The inoculum ratio was
10% (v/v). When glucose concentration in the medium
was below 10 g l
-1, feeding solution containing 500 g
l
-1 glucose was supplied to the medium. The culture
Table 2 Strains and plasmids used in this study
Strains Genotype Reference
W3110 F
-, l
-, rph-1, IN (rrnD, rrnE) Lab stock
DH5a F
-, endA1, hsdR17 (rK
-, mK
+), supE44, thi-l, l
-, recA1, gyrA96, ΔlacU169 (F80lacZ ΔM15) Lab stock
GPT100 W3110 ΔtrpR::FRT, ΔtnaA::FRT, ΔptsG::FRT This study
GPT101 GPT100 with tryptophan attenuator deletion and trp promoter swapping by 5CPtacs promoter cluster This study
GPT1001 GPT100 containing pTAT This study
GPT1002 GPT101 containing pTAT This study
Plasmids Genotype Reference
pBluescript SK
- Ap
R Lab stock
pCL1920 Spc
R [33]
pTAT pCL1920 containing aroG
FR, trpE
FR, and tktA This study
pKD4 bla, FRT-cat-FRT [34]
pKD3 bla, FRT-kan-FRT [34]
pKD46 bla, helper plasmid [34]
pCP20 bla and cat, helper plasmid [35]
p5TG pCL1920 containing 5CPtacs promoter cluster and gfp [22]
pKMT pBluescript SK
-, containing kan and 5CPtacs promoter cluster This study
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Page 7 of 9temperature was 37°C, and the pH was controlled at
6.8 with NH3·H2O. The dissolved oxygen concentra-
tion was kept at 30% via changing fermentor agitation
speed and aeration rate.
Analytical methods
Cell growth was monitored by OD600 with a spectro-
photometer (Shimazu, Japan). Glucose was quantitatively
analyzed by high-performance liquid chromatography
(HPLC; Shimazu, Japan) equipped with a column of
Aminex HPX-87H Ion Exclusion particles (300 mm ×
7 . 8m m ,B i o - R a d ,H e r c u l e s ,C A ,U S A ) .S a m p l e sw e r e
centrifuged at 12 000 rpm for 5 min and then filtrated
with a 0.22 μm aqueous membrane. The mobile phase
was 5 mM sulfuric acid (in Milli-Q water) with the flow
of 0.6 ml min
-1 and the column was maintained at 65°C.
L-tryptophan was determined by the method of fluoro-
metric determination [36].
Table 3 Primers used in this study
Primers Nucleotide sequence
trpR-F 5’-GGACGTCGTTACTGATCCGCACGTTTATGATATGCTATCGTGTAGGCTGGAGCTGCTTC-3’
trpR-R 5’-ACGGGTATTTGTAGGACGGATAAGGCGTTCACGCCGCATATGGGAATTAGCCATGGTCC-3’
tnaA-F 5’-CAGATCAACGGCTGTACCGTGCGTAACGTCTATATCAAAGTGTAGGCTGGAGCTGCTTC-3’
tnaA-R 5’-TGTTTACCGGTTTTCGGATCGCGGCCTAACAGGAAAGAGATGGGAATTAGCCATGGTCC-3’
ptsG-F 5’-ACGTAAAAAAAGCACCCATACTCAGGAGCACTCTCAATTGTGTAGGCTGGAGCTGCTTC-3’
ptsG-R 5’-AGCCATCTGGCTGCCTTAGTCTCCCCAACGTCTTACGGAATGGGAATTAGCCATGGTCC-3’
kan-F 5’-ATAGGATCCGTGTAGGCTGGAGCTGCTTC-3’
kan-R 5’-GGGGAATTCATGGGAATTAGCCATGGTCC-3’
Mtac-F 5’-GGGGAATTCTTGACAATTAATCATCGGCTCGTATA-3’
Mtac-R 5’-GGGGTCGACATGCATCTAGTATTTCTCCTCTTTAATGGAT-3’
trp-F 5’-GTGCAGGTCGTAAATCACTGCATAATTCGTGTCGCTCAAGTGTAGGCTGGAGCTGCTTC-3’
trp-R 5’-GCAGGTTAGCAGTTCGAGAGTCGGTTTTTGTGTTTGCATATGCATCTAGTATTTCTCCT-3’
trp test-F 5’-GCCTTACCGCCAGAATGATGAATGA-3’
trp test-R 5’-GCAGCACACGGCAGTTTGGTGATTG-3’
trpRtest-F 5’-GTGCTGGCTTATGACGCTTACTACCGCTAT-3’
trpRtest-R 5’-CGCTGAGTCCGTTTCATAATGCCGTGTA-3’
tnaAtest-F 5’-TATCAATACACCATTCCGACTCACC-3’
tnaAtest-R 5’-GTGAAGTGACGCAATACTTTCGGTT-3’
ptsGtest-F 5’-CCTGTACACGGCGAGGCTCT-3’
ptsGtest-R 5’-AATAACACCTGTAAAAAAGGCAGCC-3’
trpE
FR -F 5’-GCCAAGCTTAAGGAGATATAATGCAAACACAAAAACCGAC-3’
trpE
FR -R 5’-ATTAACTGCAGTCAGAAAGTCTCCTGTGCATGATGCG-3’
aroG
FR -F 5’-GGGGCCTGCAGAAGGAGATATAATGAATTATCAGAACGACG-3’
aroG
FR -R 5’-TTATTGGATCCTTACCCGCGACGCGCTTTTACTGCATT-3’
tktA-F 5’-GGCGGATCCAAGGAGATATAATGTCCTCACGTAAAGAG-3’
tktA-R 5’-CGTGAGCTCTTACAGCAGTTCTTTTGCTTTCGCAACAACG-3’
Primers for RT-PCR
trpERT-F 5’-CACAATCCAGGCACTTTCCG-3’
trpERT-R 5’-GGCGTCTTCATCCAGCAGTG-3’
trpDRT-F 5’-GTGCTGATGCTTTCTCCTGG-3’
trpDRT-R 5’-CCTGATGTCCGAGGCAAATG-3’
trpCRT-F 5’-CAGACAAGGCGATTTGGGTA-3’
trpCRT-R 5’-TTGACGGCGACGCTTTCTTG-3’
trpBRT-F 5’-GGCAGGCGTTGCTGGCGAAG-3’
trpBRT-R 5’-GTTAGGCGACTGGCGTTCAA-3’
trpART-F 5’-TCTGTTTGCCCAGTTGAAGG-3’
trpART-R 5’-GGGATACCTAACTCCAGCG-3’
aroGRT-F 5’-TGGGCTGGAAAGGGCTGATT-3’
aroGRT-R 5’-GAGAAACTCACCTGCCGCTG-3’
gapART-F 5’-AACTGAATGGCAAACTGACTGGTA-3’
gapART-R 5’-TTTCATTTCGCCTTCAGCAGC-3’
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